Correlation Between NYSE Composite and Briacell Therapeutics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Briacell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Briacell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Briacell Therapeutics Corp, you can compare the effects of market volatilities on NYSE Composite and Briacell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Briacell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Briacell Therapeutics.
Diversification Opportunities for NYSE Composite and Briacell Therapeutics
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between NYSE and Briacell is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Briacell Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Briacell Therapeutics and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Briacell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Briacell Therapeutics has no effect on the direction of NYSE Composite i.e., NYSE Composite and Briacell Therapeutics go up and down completely randomly.
Pair Corralation between NYSE Composite and Briacell Therapeutics
Assuming the 90 days trading horizon NYSE Composite is expected to under-perform the Briacell Therapeutics. But the index apears to be less risky and, when comparing its historical volatility, NYSE Composite is 19.57 times less risky than Briacell Therapeutics. The index trades about -0.03 of its potential returns per unit of risk. The Briacell Therapeutics Corp is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 63.00 in Briacell Therapeutics Corp on September 24, 2024 and sell it today you would lose (8.91) from holding Briacell Therapeutics Corp or give up 14.14% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 98.46% |
Values | Daily Returns |
NYSE Composite vs. Briacell Therapeutics Corp
Performance |
Timeline |
NYSE Composite and Briacell Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Briacell Therapeutics Corp
Pair trading matchups for Briacell Therapeutics
Pair Trading with NYSE Composite and Briacell Therapeutics
The main advantage of trading using opposite NYSE Composite and Briacell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Briacell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Briacell Therapeutics will offset losses from the drop in Briacell Therapeutics' long position.NYSE Composite vs. Kulicke and Soffa | NYSE Composite vs. United Microelectronics | NYSE Composite vs. Chester Mining | NYSE Composite vs. NetEase |
Briacell Therapeutics vs. Fate Therapeutics | Briacell Therapeutics vs. Sana Biotechnology | Briacell Therapeutics vs. Caribou Biosciences | Briacell Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |